Assessing Osteolytic Lesion Size on Sequential CT Scans Is a Reliable Study Endpoint for Bone Remineralization in Newly Diagnosed Multiple Myeloma
Jan‐Peter Grunz(Universitätsklinikum Würzburg), Franziska Jundt(Comprehensive Cancer Center Mainfranken), Dirk Hasenclever(Franklin University), Stefan Knop(University of Tübingen), Malte Maria Sieren(Universitäres Kinderwunschzentrum Lübeck), Freerk T. Baumann(University Hospital Cologne), Andreas Steven Kunz(Universitätsklinikum Würzburg), Stefan Heldmann(Fraunhofer Institute for Digital Medicine), Thorsten Alexander Bley(Universitätsklinikum Würzburg), Hermann Einsele(Universitätsklinikum Würzburg)
Cited by 1
Related Papers
A Biologic Definition of Burkitt's Lymphoma from Transcriptional and Genomic Profiling
|New England Journal of Medicine|2006|1k
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders
|Leukemia|2008|808
Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma
|New England Journal of Medicine|2023|719